Immuron Limited (IMRN) Financials
IMRN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 13.5 million | 1.6 million |
2023-06-30 | 14.6 million | 1.6 million |
2023-03-31 | 14.8 million | 1.6 million |
2022-12-31 | 15.7 million | 1.3 million |
IMRN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-06-30 | -1.0 million | 75284 |
2023-03-31 | -538190 | 76157 |
2022-12-31 | -646787 | ? |
IMRN Net Income
No data available :(
IMRN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 11.2 million | - | - |
2023-06-30 | 12.6 million | - | 125449 |
2023-03-31 | 11.5 million | - | - |
2022-12-31 | 13.0 million | - | 131326 |
IMRN Shares Outstanding
IMRN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 1.8 million | - | - |
2023-06-30 | 445 | 710207 | 783186 | 154788 |
2023-03-31 | 225 | 359221 | 792268 | 156583 |
2022-12-31 | 4813 | 1.0 million | 633455 | 156940 |
IMRN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.6 million | 528165 |
2023-06-30 | 810086 | 225454 |
2023-03-31 | 409740 | 30569 |
2022-12-31 | 397566 | 106077 |
IMRN
Price: $2.52
52 week price:
Earnings Per Share: -0.44 USD
P/E Ratio: -3.98
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1327
Ebitda: -6.8 millionMarket Capitalization: 16.2 million